Literature DB >> 20889346

1,6-AnhMurNAc derivatives for assay development of amidase AmiD.

Frédéric Mercier1, Astrid Zervosen, Nathalie Teller, Jean-Marie Frère, Raphaël Herman, Anne Pennartz, Bernard Joris, André Luxen.   

Abstract

Various peptidoglycan fragments were synthesized from two anhydro-muramic acid derivatives protected with a Bn or a PMB group at the 4th position, in homogenate phase or on a solid support. In order to facilitate HPLC detection, a chromophoric group was attached to the peptide chain. The periplasmic amidase sAmiD of Escherichia coli was used to cleave the amide bond between the lactyl group of the MurNAc and the α-amino group of L-Ala where the peptide chain was at least a dipeptide (L-Ala-γ-D-Glu) amidated by benzylamine on the γ-carboxyl group of D-Glu. In the presence of a tripeptide chain (L-Ala-γ-D-Glu-L-Lys) or a tetrapeptide chain (L-Ala-γ-D-Glu-m-A(2)pm-D-Ala) higher hydrolysis rates were observed. We have also demonstrated that the presence of TNB on the ε-amino group of L-Lys only has a small influence on the hydrolysis capacity of sAmiD.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889346     DOI: 10.1016/j.bmc.2010.09.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Induction of AmpC-Mediated β-Lactam Resistance Requires a Single Lytic Transglycosylase in Agrobacterium tumefaciens.

Authors:  Wanda M Figueroa-Cuilan; Matthew Howell; Christopher Richards; Amelia Randich; Akhilesh K Yadav; Felipe Cava; Pamela J B Brown
Journal:  Appl Environ Microbiol       Date:  2022-05-31       Impact factor: 5.005

2.  Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responses.

Authors:  Michael W Panas; Jaimie D Sixsmith; KeriAnn White; Birgit Korioth-Schmitz; Shana T Shields; Brian T Moy; Sunhee Lee; Joern E Schmitz; William R Jacobs; Steven A Porcelli; Barton F Haynes; Norman L Letvin; Geoffrey O Gillard
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.